Suppression of neuropathic pain by a naturally-derived peptide with NMDA antagonist activity. (Q48708586)

14 February 2018

title

Suppression of neuropathic pain by a naturally-derived peptide with NMDA antagonist activity. (English)

1 reference

14 February 2018

0 references

Siegan JB

1

1 reference

14 February 2018

Hama AT

series ordinal

2

1 reference

14 February 2018

Sagen J

series ordinal

3

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 May 1997

1 reference

14 February 2018

published in

Brain Research

1 reference

14 February 2018

volume

755

1 reference

14 February 2018

issue

2

1 reference

14 February 2018

page(s)

331-334

1 reference

14 February 2018

Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

A cure for wind up: NMDA receptor antagonists as potential analgesics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

Activity-dependent neuronal plasticity following tissue injury and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

Adrenal medullary implants reduce transsynaptic degeneration in the spinal cord of rats following chronic constriction nerve injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

Induction of spinal NADPH-diaphorase by nerve injury is attenuated by adrenal medullary transplants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

Loss of GABA-immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

Isolation and characterization of histogranin, a natural peptide with NMDA receptor antagonist activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

N-methyl-D-aspartate receptor antagonist activity and phencyclidine-like behavioral effects of the pentadecapeptide, [Ser1]histogranin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

Attenuation of NMDA-induced spinal hypersensitivity by adrenal medullary transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

Ketamine hydrochloride in the treatment of phantom limb pain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nerve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

The induction and maintenance of central sensitization is dependent on N -methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900183-2

10.1016/S0006-8993(97)00183-2

7 January 2021

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018